Drug    DrugBank | All Description Patterns💬 Info on mouse-over

15 / 17,542 descriptions

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes
Disease ID
 1  Gene activated human glucocerebrosidase  [1] 19 💬 
 2  Gene activated human glucocerebrosidase, velaglucerase alfa  Velaglucerase alfa  [1] D09029 💬  [1] GBA 💬  [4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism  [1] 19 💬 
 3  Gene-activated human glucocerebrosidase  [1] 19 💬 
 4  Gene-activated human glucocerebrosidase 200u/vial  [1] 19 💬 
 5  Gene-activated human glucocerebrosidase 400u/vial  [1] 19 💬 
 6  Glucocerebrosidase  [1] 19 💬 
 7  Glucocerebrosidase umano gene-attivato  [1] 19 💬 
 8  Human glucocerebrosidase (prgcd)  Taliglucerase alfa  [1] D09675 💬  [1] GBA 💬  [4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism  [1] 19 💬 
 9  Plant cell expressed recombinant glucocerebrosidase (prgcd)  Taliglucerase alfa  [1] D09675 💬  [1] GBA 💬  [4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism  [1] 19 💬 
 10  Plant cell recombinant glucocerebrosidase  [1] 19 💬 
 11  Recombinant human derived macrophage-targeted beta-glucocerebrosidase  [1] 19 💬 
 12  Recombinant human derived macrophage-targeted ß-glucocerebrosidase  [1] 19 💬 
 13  Recombinant human glucocerebrosidase  [1] 19 💬 
 14  Recombinant human glucocerebrosidase (prgcd)  Taliglucerase alfa  [1] D09675 💬  [1] GBA 💬  [4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism  [1] 19 💬 
 15  Taliglucerase alfa - recombinant human glucocerebrosidase  Taliglucerase alfa  [1] D09675 💬  [1] GBA 💬  [4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism  [1] 19 💬